Mahendran Sophie A
Ferncroft Farm, Dorset, UK.
Vet Rec Open. 2020 Nov 4;7(1):e000415. doi: 10.1136/vetreco-2020-000415. eCollection 2020.
This study explored the combined use of fever detection and thoracic ultrasonography to identify calves with early onset bovine respiratory disease (BRD). Thoracic ultrasonography was then used to assess the efficacy of antimicrobial and non-steroidal anti-inflammatory drug (NSAID) treatment for early onset BRD through a randomised study design.
Calves were recruited from a single dairy farm in the UK, and fitted with a TempVerified FeverTag, which was activated when a calf developed fever (a temperature of 39.7°C for six hours). On identification of fever, a Wisconsin calf score was used to provide a diagnosis of BRD by exclusion of other causes. Calves were randomly assigned to experimental groups; group 1 (NSAID) received flunixin meglumine, group 2 (antimicrobial) received florfenicol, group 3 (both) received both drugs. A thoracic ultrasound was conducted within 48 hours of fever detection, and again 14 days later to assess lung pathology.
A total of 152 calves were recruited, with a relative BRD prevalence of 49 per cent (74/152). Thirty-two calves required a secondary treatment (due to continued fever), causing exclusion from statistical analysis of the change in ultrasound score and resulting in the study being underpowered for detecting statistical significance. Initial thoracic ultrasound scores were very low, with 70/74 calves scoring either 0 or 1, indicating few comet tails and no lung consolidation was seen and potential overdiagnosis of BRD. For assessment of therapy efficacy, no effect of experimental group was detected on average daily growth rates (mean 0.85 kg/day, P=0.89). Calves also displayed very few clinical signs at the time of fever detection. These factors combined suggest a high rate of false positive identification (low specificity) for BRD through fever detection alone. Calves given the NSAID only were more likely to require repeat treatments due to fever recurrence (OR=3.10 (95 per cent CI 0.86 to 11.15), P=0.083). Also calves affected by their first case of fever at an older age (21 v 28 days old) were less likely to go on to have further fever episodes (OR=0.95 (95 per cent CI 0.90 to 0.99), P=0.026).
This study demonstrated calves given only an NSAID at occurrence of fever due to BRD may be more likely to require repeat treatments throughout the preweaning period. The use of fever detection alone for BRD indicated a low specificity for definitive diagnosis as shown by the low thoracic ultrasound scores and lack of clinical signs. The study was underpowered to assess the ultrasonic effects of the different treatment protocols on lung pathology.
本研究探讨了发热检测与胸部超声检查相结合的方法,以识别早发性牛呼吸道疾病(BRD)的犊牛。随后通过随机研究设计,利用胸部超声检查评估抗菌药物和非甾体抗炎药(NSAID)对早发性BRD的治疗效果。
从英国的一个奶牛场招募犊牛,并为其佩戴TempVerified FeverTag,当犊牛发热(体温39.7°C持续6小时)时该标签被激活。在确定发热后,使用威斯康星犊牛评分法,通过排除其他病因来诊断BRD。将犊牛随机分配到实验组;第1组(NSAID组)接受氟尼辛葡甲胺,第2组(抗菌药物组)接受氟苯尼考,第3组(联合用药组)接受两种药物。在检测到发热后的48小时内进行胸部超声检查,并在14天后再次检查以评估肺部病理情况。
共招募了152头犊牛,BRD相对患病率为49%(74/152)。32头犊牛需要二次治疗(由于持续发热),导致其被排除在超声评分变化的统计分析之外,使得该研究检测统计学显著性的效能不足。初始胸部超声评分非常低,74头犊牛中有70头评分为0或1,表明几乎没有彗尾征且未见肺部实变,可能存在BRD的过度诊断。为评估治疗效果,未检测到实验组对平均日生长率有影响(平均0.85千克/天,P = 0.89)。犊牛在发热检测时也几乎没有临床症状。这些因素综合表明,仅通过发热检测诊断BRD的假阳性率较高(特异性低)。仅接受NSAID治疗的犊牛因发热复发而更有可能需要重复治疗(OR = 3.10(95%CI 0.86至11.15),P = 0.083)。此外,首次发热时年龄较大(21天对28天)的犊牛发生进一步发热的可能性较小(OR = 0.95(95%CI 0.90至0.99),P = 0.026)。
本研究表明,因BRD发热时仅接受NSAID治疗的犊牛在断奶前阶段可能更有可能需要重复治疗。仅使用发热检测诊断BRD显示出较低的特异性,如胸部超声评分低和缺乏临床症状所示。该研究评估不同治疗方案对肺部病理的超声影响的效能不足。